DURECT Appoints Timothy Papp As New CFO
(RTTNews) - Biopharmaceutical company DURECT Corp. (DRRX) announced Tuesday the appointment of Timothy Papp as its Chief Financial Officer. Papp brings over 25 years of corporate finance experience to DURECT, including 15 years in the Biopharma sector.
In this new role, Papp will direct and oversee all financial and capital markets activities including accounting, financial reporting, financial planning and analysis, financial strategy, and investor relations.
Papp joins DURECT from RBC Capital Markets, where he was a Managing Director of Healthcare Investment Banking. Previously, he served as a Managing Director of Healthcare Investment Banking at Stifel, and he also served in Investment Banking and Mergers & Acquisitions roles at Cowen, Keybanc Capital Markets, and Rodman & Renshaw.
DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line
Technology, Materials Stocks Climb Higher; TSX Up Over 1%
Bay Street Looks Set To Open On Firm Note
Dollar Declines Amidst Uncertain Fed Policy Outlook
FTSE 100 Advances Amid Optimism About An End To US Government Shutdown
CAC 40 Rises 1.3% On Prospects Of An End To US Government Shutdown
DAX Up Sharply As Stocks Rally On Hopes Of An End To U.S. Government Shutdown
